畜牧兽医学报 ›› 2025, Vol. 56 ›› Issue (1): 343-352.doi: 10.11843/j.issn.0366-6964.2025.01.032

• 预防兽医 • 上一篇    下一篇

猪胸膜肺炎放线杆菌OmpD、LppB蛋白的原核表达及免疫原性分析

曾焱1(), 欧祥龙1, 闫晓阳1, 刘灿1, 廖永洪1,2,*()   

  1. 1. 西南大学动物医学院, 重庆 402460
    2. 国家生猪技术创新中心, 重庆 402460
  • 收稿日期:2024-01-26 出版日期:2025-01-23 发布日期:2025-01-18
  • 通讯作者: 廖永洪 E-mail:2685343085@qq.com;yonghongliao@swu.edu.cn
  • 作者简介:曾焱(1999-),女,重庆永川人,硕士生,主要从事动物细菌病疫苗研究与开发研究,E-mail: 2685343085@qq.com
  • 基金资助:
    国家自然科学基金面上项目(32473062);“十四五”国家重点研发计划项目(2022YFD1800902);中央高校基本科研业务费-人才引进项目(SWU020020);国家生猪技术创新中心项目(NCTIP-XD/B11;NCTIP-XD/C17)

Prokaryotic Expression and Immunogenicity Analysis of OmpD and LppB of Actinobacillus pleuropneumoniae

ZENG Yan1(), OU Xianglong1, YAN Xiaoyang1, LIU Can1, LIAO Yonghong1,2,*()   

  1. 1. College of Veterinary Medicine, Southwest University, Chongqing 402460, China
    2. National Center of Technology Innovation for Pigs, Chongqing 402460, China
  • Received:2024-01-26 Online:2025-01-23 Published:2025-01-18
  • Contact: LIAO Yonghong E-mail:2685343085@qq.com;yonghongliao@swu.edu.cn

摘要:

本研究旨在评价猪胸膜肺炎放线杆菌OmpD和LppB蛋白的免疫原性和保护效果。通过同源性分析,发现19个血清型的APP均含有ompDlppB基因,氨基酸序列相似性分别为98.2%~100%和99.3%~100%。利用基因工程大肠杆菌表达纯化了1型菌株的rOmpD和rLppB蛋白,并进行了免疫原性分析。结果显示,两种蛋白均能有效表达,与猪康复血清反应明显。小鼠免疫rOmpD、rLppB蛋白后,ELISA抗体水平显著提高,对国内流行的1型、7型菌株攻毒保护率为70%~80%。进一步制备含rOmpD和rLppB的油乳剂,免疫仔猪后,ELISA抗体水平显著提高,对1型、7型菌株攻毒具有部分保护作用和交叉保护能力,但未能完全阻止感染和死亡。因此OmpD、LppB有作为APP亚单位疫苗开发候选抗原的潜力,本研究为进一步开发具有良好交叉保护效果的疫苗提供了数据支持。

关键词: 猪胸膜肺炎放线杆菌, OmpD, LppB, 免疫原性, 免疫效果

Abstract:

This study evaluated the immunogenicity and protective efficacy of OmpD and LppB proteins from Actinobacillus pleuropneumoniae. Homology analysis revealed that all 19 serotypes of APP have ompD and lppB genes, with amino acid sequence identities of 98.2%-100% and 99.3%-100%, respectively. Recombinant OmpD (rOmpD) and LppB (rLppB) proteins from serotype 1 were expressed and purified using engineered E. coli and subjected to immunogenicity analysis. The results showed that both proteins were effectively expressed and exhibited obvious reactivity with swine convalescent serum. Mice immunized with rOmpD or rLppB leaded to significantly elevated ELISA antibody titers and protection rates of 70%-80% against challenge with prevalent serotype 1 and 7 strains. Further, an oil emulsion containing rOmpD and rLppB was prepared, and immunization of piglets elicited significantly elevated ELISA antibody titers and conferred partial protection and cross-protection against serotype 1 and 7 challenge. However, complete protection against infection and death was not achieved. These findings suggest that OmpD and LppB are promising candidates for subunit vaccine development against Actinobacillus pleuropneumoniae, and provide valuable data for the further development of vaccines with cross-protective efficacy.

Key words: Actinobacillus pleuropneumoniae, OmpD, LppB, immunogenicity, efficacy

中图分类号: